Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Telling founders no Board meeting etiquette|Michael Luciani,Managing Partner,Climate Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Partner at Climate Capital.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Paul Canvert: Driving Recruitment & Retention in Transport | Paul Sarant - CEO, MD & Executive Director of K&S Corporation Limited
00:10:00
Undray Wilks: Reflecting on Black History Month at Morgan Lewis | UNDRAY WILKS - PARTNER of Morgan, Lewis & Bockius LLP
00:10:00
Leading Diversity, Equity, and Inclusion: A Strategic Approach by MFS Investment Management CEO Mike Roberge | Mike Roberge, CEO , MFS Investment Management.
00:10:00
Meet the Guide Financial Planning Team: Your Trusted Experts in Financial Success | Ben Wacek - FOUNDER & FINANCIAL PLANNER of Guide Financial Planning, LLC
00:10:00
Investing and co-building with blockchain startups|Arul Murugan,Founding Managing Partner and Chairman,Borderless Capital
00:10:00
Unlocking Financial Freedom with a Holistic Approach: F5 Financial’s Unique Process | Curt Stowers, Founder , F5 Financial Planning.
00:10:00
Gary Economou Discusses Focus Graphite’s High-Grade Deposit and Growing Market Demand
00:00:00
Interested in the evolution of transcriptional networks in animals / Angela H. DePace Associate Professor of Systems Biology, HMS
00:10:00
Insights into Macro Trends and Investment Strategy: A Discussion with Karen Karniol-Tambour, Co-CIO of Bridgewater Associates, at GIC Insights 2023
00:10:00
"Shaping Burlingame’s Economic Future: A Deep Dive into Business Growth and City Planning with Lisa Goldman, City Manager"
00:00:00
Oncimmune's strategic pivot aims for robust growth in 2024 - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings
00:10:00
Invests in technical founders building the next generation of applications|Barr Yaron,Principal,Amplify Partners